home / stock / meip / meip articles
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future g...
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future g...
RICHARD GHALIE, Chief Medical Officer at MEI Pharma (NASDAQ:MEIP), reported a large acquisition of company stock options on October 12, according t...
Anson Funds Management LP, 10% Owner at MEI Pharma (NASDAQ:MEIP), reported a large insider buy on September 25, according to a new SEC filing. Wha...
News, Short Squeeze, Breakout and More Instantly...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...
– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping Toxicity – – MEI to Continue Advancing ME-344 via Dev...
MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso, president and chief executive officer of MEI Pharma, will participate in a firesi...